Dystonia with MPH/Risperidone Combined Therapy for ADHD
J Gordon Millichap1, Michelle M Yee1
1Division of Neurology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL; Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL.
Pediatric Neurology Briefs
|March 23, 2016
Summary
This case study highlights extrapyramidal symptoms in a 13-year-old boy with multiple psychiatric diagnoses. The symptoms improved with a combination of risperidone, oxcarbazepine, and methylphenidate (MPH).
Area of Science:
- Child Neurology
- Pediatric Psychiatry
- Neuropharmacology
Background:
- Extrapyramidal symptoms (EPS) are common adverse effects of antipsychotic medications.
- Co-occurring psychiatric conditions in adolescents can complicate treatment and symptom management.
- Understanding medication responses in complex pediatric cases is crucial for effective care.
Purpose of the Study:
- To report a case of extrapyramidal symptoms in an adolescent with a complex psychiatric history.
- To describe the treatment response to a specific medication combination for these symptoms.
Main Methods:
- Case report of a 13-year-old male patient.
- Review of psychiatric history including schizophrenia, bipolar disorder, ADHD, and autism.
- Observation of extrapyramidal symptoms and their response to pharmacological intervention.
Main Results:
- The patient presented with extrapyramidal symptoms.
- Symptoms showed improvement following the administration of a combination therapy.
- The treatment regimen included risperidone, oxcarbazepine, and methylphenidate (MPH).
Conclusions:
- Combination therapy with risperidone, oxcarbazepine, and MPH can be effective in managing extrapyramidal symptoms in adolescents with complex psychiatric profiles.
- This case underscores the importance of individualized treatment approaches in pediatric neurology and psychiatry.
- Further research may be warranted to explore the efficacy of this specific combination in similar patient populations.
More Related Videos
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
1.3K
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
1.3K
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:28Drug Therapy
391
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
391
01:23Antidepressant Drugs: MAOIs and Other Agents
1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
1.1K
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
1.1K
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.7K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.7K